SYN-TECH Chemical & Pharmaceutical Co. Ltd.(TW:1777)
NT$74.800.00 (0.00%)
TW:1777
SYN-TECH Chemical & Pharmaceutical Co. Ltd. financials statements
NT$74.80
At close:0.00 (0.00%)
SYN-TECH Chemical & Pharmaceutical Co. Ltd. (1777) Income Statement
SYN-TECH Chemical & Pharmaceutical Co. Ltd. Income Statement
Last quarter (Q2 2026), SYN-TECH Chemical & Pharmaceutical Co. Ltd.'s total revenue was NT$336.40M, an increase of 3.56% from the same quarter last year. In Q2, SYN-TECH Chemical & Pharmaceutical Co. Ltd.'s net income was NT$90.57M. See SYN-TECH Chemical & Pharmaceutical Co. Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 1.30B | NT$ 1.26B | NT$ 1.11B | NT$ 986.30M | NT$ 893.23M | |
| NT$ 444.11M | NT$ 486.94M | NT$ 409.52M | NT$ 360.98M | NT$ 284.01M | |
| NT$ 124.25M | NT$ 135.96M | NT$ 127.67M | NT$ 122.75M | NT$ 115.43M | |
| Depreciation and Amortization | NT$ 147.13M | NT$ 143.99M | NT$ 111.75M | NT$ 80.85M | NT$ 71.45M |
| NT$ 467.00M | NT$ 634.37M | NT$ 430.56M | NT$ 319.08M | NT$ 240.04M | |
| NT$ 319.86M | NT$ 350.98M | NT$ 281.85M | NT$ 238.23M | NT$ 168.59M | |
| NT$ 14.06M | NT$ 137.25M | NT$ 31.92M | NT$ 128.59M | NT$ 32.37M | |
| NT$ 333.92M | NT$ 488.24M | NT$ 313.77M | NT$ 366.82M | NT$ 200.96M | |
| NT$ 261.61M | NT$ 393.28M | NT$ 251.01M | NT$ 295.29M | NT$ 177.16M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 5.87 | NT$ 8.81 | NT$ 5.63 | NT$ 6.62 | NT$ 5.03 |
| Diluted EPS | NT$ 5.85 | NT$ 8.81 | NT$ 5.62 | NT$ 6.61 | NT$ 5.02 |
| Weighted Average Shares Outstanding | 44.59M | 44.59M | 44.58M | 44.59M | 35.25M |
| Weighted Average Shares Outstanding (Diluted) | 44.71M | 44.70M | 44.68M | 44.66M | 35.28M |
Currency in TWD
